Welcome to CDC Stacks | The cost-effectiveness of routine testing for Lynch syndrome in newly diagnosed patients with colorectal cancer in the United States: corrected estimates - 32326 | CDC Public Access
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
The cost-effectiveness of routine testing for Lynch syndrome in newly diagnosed patients with colorectal cancer in the United States: corrected estimates
Filetype[PDF - 38.66 KB]


Details:
No Related Documents.
You May Also Like:
  1. When is Genomic Testing Cost-Effective? Testing for Lynch Syndrome in Patients with Newly-Diagnosed Colorectal Cancer and Their Relatives
    Personal Author:
    Grosse, Scott D.
    Published:
    2015
    Source:
    Healthcare (Basel). 3(4):860-878.
    Description:
    Varying estimates of the cost-effectiveness of genomic testing applications can reflect differences in study questions, settings, methods and assumptions. This review compares recently published cost-effectiveness analyses of testing strategies for L...
    File Type:
    Filetype[PDF - 231.06 KB]
  2. Cost-Effectiveness of Frequent HIV Testing of High-Risk Populations in the United States
    Personal Author:
    Hutchinson, Angela B.; Farnham, Paul G.; Sansom, Stephanie L.; Yaylali, Emine; Mermin, Jonathan H.;
    Published:
    Mar 1 2016
    Source:
    J Acquir Immune Defic Syndr. 2015; 71(3):323-330.
    Description:
    Purpose: : Data showing a high incidence of HIV infection among men who have sex with men (MSM) who had annual testing suggest that more frequent HIV testing may be warranted. Testing technology is also a consideration given the availability of sensi...
    File Type:
    Filetype[PDF - 232.09 KB]
  3. Cost-effectiveness of a 12-dose regimen for treating latent tuberculous infection in the United States
    Personal Author:
    Shepardson, D.; Marks, S. M.; Chesson, H.; Kerrigan, A.; Holland, D. P.; Scott, N.; Tian, X.; Borisov, A. S.; Shang, N.; Heilig, C. M.; Sterling, T. R.; Villarino, M. E.; Mac Kenzie, W. R.;
    Published:
    Dec 2013
    Source:
    Int J Tuberc Lung Dis. 17(12):1531-1537.
    Description:
    SETTING : A large randomized controlled trial recently showed that for treating latent tuberculous infection (LTBI) in persons at high risk of progression to tuberculosis (TB) disease, a 12-dose regimen of weekly rifapentine plus isoniazid (3HP) admi...
    File Type:
    Filetype[PDF - 910.88 KB]
  4. Cost-effectiveness of Human Papillomavirus Vaccination in the United States
    Personal Author:
    Chesson, Harrell W.; Ekwueme, Donatus U.; Saraiya, Mona; Markowitz, Lauri E.;
    Published:
    Feb 2008
    Source:
    Emerg Infect Dis. 14(2):244-251.
    Description:
    We describe a simplified model, based on the current economic and health effects of human papillomavirus (HPV), to estimate the cost-effectiveness of HPV vaccination of 12-year-old girls in the United States. Under base-case parameter values, the est...
    File Type:
    Filetype[PDF - 365.12 KB]
  5. Cost-Effectiveness of Hepatitis B Vaccination in Adults With Diagnosed Diabetes
    Personal Author:
    Hoerger, Thomas J.; Schillie, Sarah F.; Wittenborn, John S.; Bradley, Christina L.; Zhou, Fangjun; Byrd, Kathy; Murphy, Trudy V.;
    Published:
    Aug 28 2012
    Source:
    Diabetes Care. 2013; 36(1):63-69.
    Description:
    OBJECTIVE : To examine the cost-effectiveness of a hepatitis B vaccination program for unvaccinated adults with diagnosed diabetes in the U.S. : RESEARCH DESIGN AND METHODS : We used a cost-effectiveness simulation model to estimate the cost-effectiv...
    File Type:
    Filetype[PDF - 322.99 KB]